CA2000763A1 - Produit dispersant - Google Patents

Produit dispersant

Info

Publication number
CA2000763A1
CA2000763A1 CA2000763A CA2000763A CA2000763A1 CA 2000763 A1 CA2000763 A1 CA 2000763A1 CA 2000763 A CA2000763 A CA 2000763A CA 2000763 A CA2000763 A CA 2000763A CA 2000763 A1 CA2000763 A1 CA 2000763A1
Authority
CA
Canada
Prior art keywords
formulation
dispersable
dispersable formulation
disintegrant
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2000763A
Other languages
English (en)
Other versions
CA2000763C (fr
Inventor
Lorraine Mary Murphy
Graham Paul Matthews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of CA2000763A1 publication Critical patent/CA2000763A1/fr
Application granted granted Critical
Publication of CA2000763C publication Critical patent/CA2000763C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CA002000763A 1988-10-18 1989-10-16 Produit dispersant Expired - Lifetime CA2000763C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888824392A GB8824392D0 (en) 1988-10-18 1988-10-18 Dispersible formulation
GB8824392.8 1988-10-18

Publications (2)

Publication Number Publication Date
CA2000763A1 true CA2000763A1 (fr) 1990-04-18
CA2000763C CA2000763C (fr) 2000-11-14

Family

ID=10645384

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002000763A Expired - Lifetime CA2000763C (fr) 1988-10-18 1989-10-16 Produit dispersant

Country Status (19)

Country Link
EP (1) EP0365480B1 (fr)
JP (1) JP2795924B2 (fr)
KR (1) KR0151131B1 (fr)
AT (1) ATE79538T1 (fr)
AU (1) AU626924B2 (fr)
CA (1) CA2000763C (fr)
DE (1) DE68902531T2 (fr)
DK (1) DK170793B1 (fr)
ES (1) ES2052065T3 (fr)
FI (1) FI94925C (fr)
GB (1) GB8824392D0 (fr)
GR (1) GR3006304T3 (fr)
IE (1) IE62557B1 (fr)
IL (1) IL91949A (fr)
NZ (1) NZ231023A (fr)
PH (1) PH30526A (fr)
PT (1) PT92002B (fr)
SA (1) SA90100079B1 (fr)
ZA (1) ZA897853B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2059260B1 (es) * 1992-10-06 1995-04-16 Espanola Prod Quimicos Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US20010014340A1 (en) * 1996-06-14 2001-08-16 Motohiro Ohta Intrabuccally rapidly disintegrating tablet
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
EP0839526A3 (fr) * 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Préparation pharmaceutique solide à dissolution ou désintégration buccale rapide
US6312724B1 (en) 1997-04-04 2001-11-06 Isa Odidi Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof
ES2559766T3 (es) 1998-05-18 2016-02-15 Takeda Pharmaceutical Company Limited Comprimidos disgregables en la boca
AU753241C (en) * 1998-06-11 2003-05-08 Pharmacia & Upjohn Company Tablet formation
AR019935A1 (es) 1998-07-28 2002-03-27 Takeda Pharmaceutical Preparacion solida de desintegracion rapida, uso de una hidroxipropil celulosa poco sustituida en dicha preparacion y metodo para mejorar la capacidad dedesintegracion rapida de la misma
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ728442A (en) 2004-10-21 2018-05-25 Adare Pharmaceuticals Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
JO3352B1 (ar) 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
TW201113266A (en) * 2009-09-02 2011-04-16 Ziopharm Oncology Inc Pharmaceutical formulations for indibulin
MX2012006240A (es) 2009-12-02 2012-10-03 Aptalis Pharma Ltd Microcapsulas de fexofenadina y composiciones que contienen las mismas.
EP2704689B1 (fr) 2012-04-19 2018-11-28 Glatt AG Compositions pharmaceutiques à goût masqué contenant du diclofénac
DE202022100544U1 (de) 2022-01-31 2022-02-16 Ranjitsing Babasing Bayas Neue orale Streifen- oder Dünnfilmform von Diclofenac-Natrium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1200178B (it) 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.
CH675537A5 (fr) * 1988-03-25 1990-10-15 Ciba Geigy Ag

Also Published As

Publication number Publication date
KR0151131B1 (ko) 1998-10-15
AU626924B2 (en) 1992-08-13
KR900005964A (ko) 1990-05-07
JPH02164824A (ja) 1990-06-25
IL91949A (en) 1993-08-18
ES2052065T3 (es) 1994-07-01
IE893336L (en) 1990-04-18
PT92002B (pt) 1995-06-30
FI94925B (fi) 1995-08-15
GR3006304T3 (fr) 1993-06-21
SA90100079B1 (ar) 1999-03-21
ATE79538T1 (de) 1992-09-15
GB8824392D0 (en) 1988-11-23
DK170793B1 (da) 1996-01-22
DE68902531T2 (de) 1993-04-08
ZA897853B (en) 1992-07-29
EP0365480A1 (fr) 1990-04-25
CA2000763C (fr) 2000-11-14
FI94925C (fi) 1995-11-27
IL91949A0 (en) 1990-06-10
NZ231023A (en) 1991-09-25
AU4297089A (en) 1990-04-26
EP0365480B1 (fr) 1992-08-19
DK515489D0 (da) 1989-10-17
DE68902531D1 (de) 1992-09-24
DK515489A (da) 1990-04-19
FI894899A0 (fi) 1989-10-16
IE62557B1 (en) 1995-02-08
JP2795924B2 (ja) 1998-09-10
PH30526A (en) 1997-06-13
PT92002A (pt) 1990-04-30

Similar Documents

Publication Publication Date Title
CA2000763A1 (fr) Produit dispersant
CA2123160A1 (fr) Formulation a liberation controlee
CA2232310A1 (fr) Compositions stables contenant du n-propargyl-1-aminoindane
CA2230314A1 (fr) Formulations pharmaceutiques contenant de la darifenacine
CA2158630A1 (fr) Formes posologiques contenant de l'acide thioctique ou des sels solides de l'acide thioctique a caracteristiques ameliorees de liberation ou de biodisponibilite
CA2102630A1 (fr) Compositions pharmaceutiques de medicaments compactes
CA2005986A1 (fr) Derive de benzimidazole ayant un effet inhibiteur sur l'acide gastrique et procede de preparation correspondant
CA2171303A1 (fr) Principes actifs et microparticules gazeuses
CA2258095A1 (fr) Compositions contenant de la tetrahydrolipstatine
CA2100212A1 (fr) Utilisation d'inhibiteurs du complement dans la preparation d'un produit pharmaceutique pour la prophylaxie et le traitement des affections inflammatoires de l'intestin et de la peau ainsi que du purpura
PL299870A1 (en) 7-beta-[(z)-2-(2-amino-4-thiasolyl)-2-hydroxyiminoacetamide]-3-(1,2,3-triazol-4-yl)-thiomethylothio-3-cephemo-4-carboxylic hydrochloride, crystalline hydrate of 7-beta-[(z)-2-(2-amino-4-thiasolyl)-2-hydroxyiminoacetamide]-3-(1,2,3-triazol-4-yl)-thiomethylothio-3-cephemo-4-carboxylic hydrochloride, method of obtaining these compounds, pharmaceutical preparation and method of fighting against bacteriae
CA2164776A1 (fr) Composition pharmaceutique, administrable par voie orale
CA2129542A1 (fr) Preparation pharmaceutique a base de rhamnolipide
CA2179733A1 (fr) Sulfamates de pseudofructopyranose anticonvulsifs
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
EP0285871A3 (en) Sustained release granulate without binding agent
CA2120001A1 (fr) Composition pharmaceutique a base de flavopereirine et son utilisation contre le vih
HRP940315A2 (en) Process for the preparation of pharmaceutical compositions containinbg active ingredient
CA2169696A1 (fr) Derives de substitution de benzenesulfonylurees et de thiourees; methodes de preparation et utilisation de preparations pharmaceutiques a base de ces composes; medicaments qui en renferment
CA2101548A1 (fr) Acides acylamino-alylidenehydroxy-bisphosphoniques, utiles pour le traitement des maladies osteoarticulaires
AP9200405A0 (en) Pharmaceutical formulations comprised of micronised halofantrine.
AU677262B2 (en) N-acyl-n-phenylmaleamic acid derivative, process for producing the same, and herbicide containing the same as active ingredient
CA2099667A1 (fr) Agent pour le traitement des hepatopathies
CA2168517A1 (fr) Derives de substitution de thiophenylsulfonylurees et -thio-urees; methodes de preparation; utilisation comme medicaments ou agents de diagnostics; medicaments a base de ces derives
AU5575594A (en) N-aryloxyacyl-n-phenyltetrahydrophthalamic acid derivative, process for producing the same, and herbicide containing the same as active ingredient

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry